Please login to the form below
33
Revenue 2017Humalog
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humalog was produced by Lilly.
Lilly joins new Medicare scheme to reduce insulin prices
Lilly has faced particularly strong criticism, after its widely-used Humalog insulin rose from $34 to $234 per vial between 2001 and 2015.
Lilly will aim for one $1bn-$5bn deal per quarter in 2020
Lilly needs to refresh its pipeline as it continues to suffer from a decline across its older, established brands – including in its diabetes franchise, where its Humalog insulin is facing generic ... The company recently announced its will launch lower
Lilly extends range of cut-price insulins in the US
Cheaper, authorised generic versions of Lilly’s Humalog Junior KwikPen and Humalog Mix75/25 products – priced at $265.20 for a pack of five which is another 50% reduction on the ... Humalog pay less than $100 for their monthly prescription at retail
Novo follows Sanofi, Lilly with insulin price cut in US
which offered a 50% cheaper version of its Humalog (insulin lispro) the following month.
The fight for affordable insulin
The price of Humalog, more commonly used by type 1 patients, also saw its price rise 585% from $35 to $234 between 2001 and 2015. ... Lilly’s authorised generic. One company, Eli Lilly, has responded to the pleas for more affordable insulins, and
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
